Shi, C., Li, M., Muhammad, I., Ma, X., Chang, Y., Li, R., Li, C., He, J., & Liu, F. (2018). Combination of berberine and ciprofloxacin reduces multi-resistant Salmonella strain biofilm formation by depressing mRNA expressions of luxS, rpoE, and ompR. Journal of veterinary science, 19(6), 808–816. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265579/
Zhang S et al.(2018). The effect of berberine on the transcriptome and proteome of E. coli. bioRxiv https://www.biorxiv.org/content/10.1101/318733v1
Zhang, D., Ke, L., Ni, Z., Chen, Y., Zhang, L. H., Zhu, S. H., Li, C. J., Shang, L., Liang, J., & Shi, Y. Q. (2017). Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial. Medicine, 96(32), e7697. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556219/
Jiang, X., Jiang, C., Huang, C., Chen, G., Jiang, K., Huang, B., & Liu, F. (2018). Berberine Combined with Triple Therapy versus Triple Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials. Evidence-based complementary and alternative medicine : eCAM, 2018, 8716910. https://pubmed.ncbi.nlm.nih.gov/30410559/
Chu M et al. Berberine: a medicinal compound for the treatment of bacterial infections. Clin Microbial. 2014;3:150. https://www.longdom.org/abstract/berberine-a-medicinal-compound-for-the-treatment-of-bacterial-infections-39119.html
Yang, Z., Wang, Q., Ma, K., Shi, P., Liu, W., & Huang, Z. (2018). Fluconazole inhibits cellular ergosterol synthesis to confer synergism with berberine against yeast cells. Journal of global antimicrobial resistance, 13, 125–130. https://pubmed.ncbi.nlm.nih.gov/29287714/
Quan, H., Cao, Y. Y., Xu, Z., Zhao, J. X., Gao, P. H., Qin, X. F., & Jiang, Y. Y. (2006). Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole. Antimicrobial agents and chemotherapy, 50(3), 1096–1099. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1426442/
GUPTE S. Use of Berberine in Treatment of Giardiasis. Am J Dis Child. 1975;129(7):866. https://jamanetwork.com/journals/jamapediatrics/article-abstract/506103
Kaneda, Y., Torii, M., Tanaka, T., & Aikawa, M. (1991). In vitro effects of berberine sulphate on the growth and structure of Entamoeba histolytica, Giardia lamblia and Trichomonas vaginalis. Annals of tropical medicine and parasitology, 85(4), 417–425. https://pubmed.ncbi.nlm.nih.gov/1796883/
Chen, C., Tao, C., Liu, Z., Lu, M., Pan, Q., Zheng, L., Li, Q., Song, Z., & Fichna, J. (2015). A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome. Phytotherapy research : PTR, 29(11), 1822–1827. https://pubmed.ncbi.nlm.nih.gov/26400188/
Han, J., Lin, H., & Huang, W. (2011). Modulating gut microbiota as an anti-diabetic mechanism of berberine. Medical science monitor : international medical journal of experimental and clinical research, 17(7), RA164–RA167. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539561/
Peng, L., Li, Z. R., Green, R. S., Holzman, I. R., & Lin, J. (2009). Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. The Journal of nutrition, 139(9), 1619–1625. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728689/
Pérez-Rubio, K. G., González-Ortiz, M., Martínez-Abundis, E., Robles-Cervantes, J. A., & Espinel-Bermúdez, M. C. (2013). Effect of berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion. Metabolic syndrome and related disorders, 11(5), 366–369. https://pubmed.ncbi.nlm.nih.gov/23808999/
Yang, J., Yin, J., Gao, H., Xu, L., Wang, Y., Xu, L., & Li, M. (2012). Berberine improves insulin sensitivity by inhibiting fat store and adjusting adipokines profile in human preadipocytes and metabolic syndrome patients. Evidence-based complementary and alternative medicine : eCAM, 2012, 363845. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310165/
Wu, L., Xia, M., Duan, Y., Zhang, L., Jiang, H., Hu, X., Yan, H., Zhang, Y., Gu, Y., Shi, H., Li, J., Gao, X., & Li, J. (2019). Berberine promotes the recruitment and activation of brown adipose tissue in mice and humans. Cell death & disease, 10(6), 468. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6565685/
DiNicolantonio, J. J., McCarty, M., & OKeefe, J. (2019). Astaxanthin plus berberine: a nutraceutical strategy for replicating the benefits of a metformin/fibrate regimen in metabolic syndrome. Open heart, 6(2), e000977. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744071/
Zhang, H., Wei, J., Xue, R., Wu, J. D., Zhao, W., Wang, Z. Z., Wang, S. K., Zhou, Z. X., Song, D. Q., Wang, Y. M., Pan, H. N., Kong, W. J., & Jiang, J. D. (2010). Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism: clinical and experimental, 59(2), 285–292. https://pubmed.ncbi.nlm.nih.gov/19800084/
Yin, J., Xing, H., & Ye, J. (2008). Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism: clinical and experimental, 57(5), 712–717. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410097/